Injecting tirzepatide from a compounded vial is straightforward once you know the steps—but it requires a provider-issued prescription and guidance from a licensed clinician before you start. TelosRX offers asynchronous online evaluation; no in-person appointment required.
Compounded tirzepatide comes as a multi-dose vial that you inject subcutaneously (under the skin) once a week. Unlike the branded auto-injector pen, this format uses a separate syringe and needle. The injection itself takes about two minutes once the technique is familiar.
This guide covers supplies, dose drawing, site selection, the standard dosing schedule, missed-dose rules, and managing common side effects. Every step touching medical decisions carries a provider-gate note—those decisions belong to your prescribing clinician, not the internet.
What You Need Before Your First Injection
Your compounded tirzepatide protocol sheet from the dispensing pharmacy takes precedence over any general guide, including this one. Read it before your first injection.
Gather these supplies:
- Compounded tirzepatide multi-dose vial (refrigerated)
- Insulin syringes — 0.5 mL or 1 mL, 29–31 gauge, ½-inch needle; one new syringe per injection
- Alcohol swabs
- Sharps disposal container
- Clean, well-lit surface
Your dose in milligrams is set by your licensed provider via a provider-issued prescription. Do not adjust it without first contacting your provider.
Step 1: Wash Your Hands and Prepare the Vial
Wash your hands thoroughly with soap and water for at least 20 seconds. Dry with a clean towel. Remove the vial from the refrigerator 10–15 minutes before injecting so it reaches room temperature—cold medication stings more on injection.
Inspect the liquid. It should be clear and colorless to slightly yellow. If you see cloudiness, particles, or unusual color, do not use it. Contact the dispensing pharmacy.
Step 2: Draw Your Dose
Wipe the rubber stopper with a fresh alcohol swab and let it air-dry for 10 seconds.
- Remove the needle cap from the syringe.
- Pull the plunger back to the milliliter mark matching your prescribed dose—this pulls air into the syringe equal to your dose.
- Push the needle through the center of the rubber stopper.
- Inject the air into the vial to equalize pressure, making it easier to draw the fluid.
- Turn the vial and syringe upside down, keeping the needle tip submerged in the liquid.
- Slowly pull the plunger past your dose mark.
- Tap the syringe gently to bring air bubbles to the top, then slowly push the plunger back to your exact dose mark to expel them.
- Remove the needle from the vial. Do not set the loaded syringe on a non-sterile surface.
Step 3: Choose and Prepare an Injection Site
Tirzepatide is injected subcutaneously into one of three sites:
- Abdomen — at least 2 inches from the navel
- Outer upper thigh — middle third of the outer surface
- Back of upper arm — outer surface (easier with assistance)
Rotate sites weekly. Repeatedly injecting the same spot can cause lipohypertrophy — a buildup of fatty tissue that slows medication absorption. Clean the chosen site with an alcohol swab and let it dry fully before injecting. Wet skin stings and increases irritation risk.
Step 4: Inject
- Pinch an inch of skin and subcutaneous tissue between two fingers at your chosen site.
- Hold the syringe like a pencil at a 45-degree angle if you're lean, or 90 degrees if you have more subcutaneous tissue. Your protocol sheet may specify which angle is appropriate for you.
- Release the skin pinch after inserting the needle.
- Push the plunger down steadily until it stops.
- Hold for 5 full seconds before removing the needle—this ensures the entire dose is delivered.
- Remove the needle and apply gentle pressure with a clean swab. Do not rub; rubbing can spread medication outside the target tissue.
Step 5: Dispose Safely and Log Your Injection
Drop the used needle (without recapping it) directly into your sharps container. Never place syringes in regular trash or recycling. Most pharmacies and local health departments offer sharps disposal programs or mail-back options.
Log the date, dose in milligrams, and injection site. Tracking site rotation prevents lipohypertrophy. A phone note or small notebook works well.
Tirzepatide Dosing Schedule
Compounded tirzepatide follows the same general escalation pattern as the branded form, adjusted to your individual protocol and tolerability. Per StatPearls tirzepatide prescribing guidance, the starting dose is 2.5 mg weekly for 4 weeks before any escalation. All dose changes are subject to provider approval:
| Weeks | Typical Dose | Notes |
|---|---|---|
| 1–4 | 2.5 mg once weekly | Initiation — body adjustment phase |
| 5–8 | 5 mg once weekly | First escalation if tolerated |
| 9–12 | 7.5 mg once weekly | Second escalation (provider-directed) |
| 13–16 | 10 mg once weekly | Third escalation (provider-directed) |
| 17+ | 12.5–15 mg weekly | Maintenance — as prescribed |
Your actual dose and timeline come from your provider-issued prescription. Never self-escalate. If side effects are difficult, contact your provider through the TelosRX patient portal before adjusting anything.
Starting your protocol? Learn more about compounded tirzepatide access at TelosRX—evaluation is fully asynchronous and takes about 10 minutes.
What to Do If You Miss a Dose
Confirm specific rules with your provider. The standard approach that branded tirzepatide prescribing information uses:
- Missed by 4 days or fewer: Take it as soon as you remember and resume your regular weekly schedule.
- Missed by more than 4 days: Skip the missed dose and take the next one on your original schedule.
- Never double-dose to make up for a missed injection.
Managing Common Side Effects
Most side effects from tirzepatide are gastrointestinal and peak during dose escalation. They generally improve as your body adjusts.
- Nausea: Eat smaller meals. Avoid high-fat or spicy food around injection day. Some people inject at night so nausea passes during sleep.
- Vomiting or diarrhea: Stay hydrated. Contact your provider if symptoms are severe or persistent before your next scheduled dose.
- Injection site reactions: Minor redness or bruising is normal and typically clears in 1–2 days. Consistent site rotation reduces recurrence.
- Reduced appetite: Maintain protein intake even when hunger signals are blunted. Muscle preservation during weight loss depends on adequate protein.
For a full review of managing GLP-1 side effects, see the TelosRX GLP-1 side-effect management guide. For muscle preservation during tirzepatide therapy, see preserving lean mass on GLP-1.
Safety Notes
Compounded tirzepatide is not FDA-approved. It is prepared by licensed compounding pharmacies under federal compounding regulations. Approval for this medication is subject to evaluation by a licensed provider; not every patient qualifies.
Do not use tirzepatide if you or a close family member have had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). If you develop severe abdominal pain—especially radiating to your back—stop the medication and seek immediate medical care. This can signal pancreatitis, a rare but serious adverse event associated with GLP-1 receptor agonists. The FDA's drug compounding guidance explains the regulatory framework for compounded medications.
Frequently Asked Questions
Can I inject tirzepatide myself at home?
Yes, subject to provider approval and instruction. Compounded tirzepatide is designed for subcutaneous self-administration. Your prescribing provider reviews your suitability and provides injection guidance as part of the onboarding process. TelosRX handles this evaluation asynchronously online—no in-person visit needed.
Where is the best place to inject tirzepatide?
The abdomen (at least 2 inches from the navel), the outer upper thigh, and the back of the upper arm are all acceptable injection sites. Most people prefer the abdomen for ease of access and consistent subcutaneous tissue depth. Rotate sites weekly to prevent lipohypertrophy.
Does tirzepatide injection hurt?
Subcutaneous injections are generally well-tolerated. Using a fine-gauge needle (29–31 gauge), letting the medication reach room temperature before injecting, and ensuring the site is fully dry all reduce discomfort. Most people describe the sensation as a brief pinch.
How long does a compounded tirzepatide vial last?
Multi-dose compounded vials are typically formulated for 4–8 weeks of use depending on concentration and dose. Your dispensing pharmacy labels the vial with a beyond-use date. Store it refrigerated and discard after that date passes, even if medication remains.
What if I accidentally inject more than prescribed?
Contact your licensed provider or a poison control center immediately. Do not inject again until instructed to do so. Potential overdose symptoms include severe nausea, vomiting, or in some patients, hypoglycemia. Your provider will guide next steps based on your situation.
Can I change my weekly injection day?
Yes, with one rule: there must be at least 72 hours (3 days) between doses. Confirm the timing adjustment with your provider before making the change to ensure it fits your specific protocol.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
Compounded tirzepatide contains the same active ingredient as Mounjaro and Zepbound but is prepared by a licensed compounding pharmacy under federal compounding regulations. It is not an FDA-approved finished drug product. Concentration, excipients, and quality can vary by pharmacy. Access requires a provider-issued prescription and evaluation.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.